Page last updated: 2024-11-02

palmidrol and Dyspepsia

palmidrol has been researched along with Dyspepsia in 1 studies

palmidrol: a cannabinoid receptor-inactive eCB-related molecule used as prophylactic in helping to prevent respiratory viral infection
palmitoyl ethanolamide : An N-(long-chain-acyl)ethanolamine that is the ethanolamide of palmitic (hexadecanoic) acid.

Dyspepsia: Impaired digestion, especially after eating.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Sarnelli, G1
Pesce, M1
Seguella, L1
Lu, J1
Efficie, E1
Tack, J1
Elisa De Palma, FD1
D'Alessandro, A1
Esposito, G1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
THE EFFECT OF DIETARY SUPPLEMENTATION WITH PALMITOYLETHANOLAMIDE ON GASTROINTESTINAL SYMPTOMS IN FUNCTIONAL DYSPEPSIA PATIENTS.[NCT05877781]100 participants (Anticipated)Interventional2021-11-29Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

1 other study available for palmidrol and Dyspepsia

ArticleYear
Impaired Duodenal Palmitoylethanolamide Release Underlies Acid-Induced Mast Cell Activation in Functional Dyspepsia.
    Cellular and molecular gastroenterology and hepatology, 2021, Volume: 11, Issue:3

    Topics: Adult; Amides; Animals; Biopsy; Case-Control Studies; Disease Models, Animal; Duodenum; Dyspepsia; E

2021